A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation (Q36417684)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation |
scientific article |
Statements
1 reference
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation (English)
1 reference
Satish Rao
1 reference
Anthony J Lembo
1 reference
Steven J Shiff
1 reference
Bernard J Lavins
1 reference
Mark G Currie
1 reference
Xinwei D Jia
1 reference
Kelvin Shi
1 reference
James E MacDougall
1 reference
James Z Shao
1 reference
Paul Eng
1 reference
Susan M Fox
1 reference
Harvey A Schneier
1 reference
Caroline B Kurtz
1 reference
Jeffrey M Johnston
1 reference
1 reference
1714-24; quiz p.1725
1 reference
Identifiers
1 reference